New Treatment Options for Newly-Diagnosed and Relapsed Chronic Lymphocytic Leukemia Elżbieta Iskierka-JażdżewskaAgnieszka ObracajTadeusz Robak Leukemia (P Wiernik, Section Editor) 31 March 2022 Pages: 775 - 795
Do Patients Benefit from a Trial of Corticosteroids at the End of Life? Sriram YennurajalingamEduardo Bruera Palliative and Supportive Care (J Hardy, Section Editor) 01 April 2022 Pages: 796 - 805
Surgery in Patients with Gastro-Entero-Pancreatic Neuroendocrine Carcinomas, Neuroendocrine Tumors G3 and High Grade Mixed Neuroendocrine-Non-Neuroendocrine Neoplasms Pernille HolmagerSeppo W. LangerUlrich Knigge Neuroendocrine Cancers (M Cives, Section Editor) 01 April 2022 Pages: 806 - 817
Current Management and Treatment of Extramammary Paget’s Disease Hiroki HashimotoTakamichi Ito Skin Cancer (T Ito, Section Editor) 04 April 2022 Pages: 818 - 830
Targeted Therapy for Melanomas Without BRAF V600 Mutations Christian MenzerJessica C. Hassel Skin Cancer (T Ito, Section Editor) Open access 05 April 2022 Pages: 831 - 842
Dermatofibrosarcoma Protuberans in Children Aseel SleiwahThomas C. WrightRachel Clancy Skin Cancer (T Ito, Section Editor) 08 April 2022 Pages: 843 - 854
Systemic Treatment of Soft Tissue Sarcomas in the Geriatric Population Mia C. Weiss Sarcoma (SH Okuno, Section Editor) 07 April 2022 Pages: 855 - 863
Targeting Angiogenic Factors for the Treatment of Medulloblastoma Zahraa SakerMahdi RizkSanaa M. Nabha Neuro-oncology (GJ Lesser, Section Editor) 12 April 2022 Pages: 864 - 886
Appropriate Selection of PARP Inhibitors in Ovarian Cancer Maria SmithBhavana Pothuri Gynecologic Cancers (JS Ferriss, Section Editor) 12 April 2022 Pages: 887 - 903
Chronic Lymphocytic Leukemia: Chemotherapy Free and Other Novel Therapies Including CAR T Julia Wiedmeier-NutorJose Leis Lymphoma (JL Muñoz, Section Editor) 18 April 2022 Pages: 904 - 919
